ES2606149T3 - Fosfato tricálcico directamente comprimible - Google Patents

Fosfato tricálcico directamente comprimible Download PDF

Info

Publication number
ES2606149T3
ES2606149T3 ES12155092.5T ES12155092T ES2606149T3 ES 2606149 T3 ES2606149 T3 ES 2606149T3 ES 12155092 T ES12155092 T ES 12155092T ES 2606149 T3 ES2606149 T3 ES 2606149T3
Authority
ES
Spain
Prior art keywords
weight
parts
particles
composition
oral dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES12155092.5T
Other languages
English (en)
Spanish (es)
Inventor
Lewis Roe Hendricks
Jill Marie Jobbins
Wayne Camarco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innophos Inc
Original Assignee
Innophos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innophos Inc filed Critical Innophos Inc
Application granted granted Critical
Publication of ES2606149T3 publication Critical patent/ES2606149T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
ES12155092.5T 2004-05-04 2005-05-04 Fosfato tricálcico directamente comprimible Expired - Lifetime ES2606149T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56792604P 2004-05-04 2004-05-04
US567926P 2004-05-04

Publications (1)

Publication Number Publication Date
ES2606149T3 true ES2606149T3 (es) 2017-03-22

Family

ID=35320719

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12155092.5T Expired - Lifetime ES2606149T3 (es) 2004-05-04 2005-05-04 Fosfato tricálcico directamente comprimible

Country Status (11)

Country Link
US (1) US7226620B2 (https=)
EP (2) EP1755556A4 (https=)
JP (1) JP5038130B2 (https=)
CN (2) CN102406593A (https=)
AU (1) AU2005240137B2 (https=)
CA (1) CA2565667C (https=)
ES (1) ES2606149T3 (https=)
HU (1) HUE033015T2 (https=)
MX (1) MXPA06012788A (https=)
NZ (1) NZ550942A (https=)
WO (1) WO2005107722A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2850282B1 (fr) 2003-01-27 2007-04-06 Jerome Asius Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
SI2719378T1 (sl) 2006-06-19 2016-11-30 Alpharma Pharmaceuticals Llc Farmacevtski sestavki
FR2919191B1 (fr) * 2007-07-25 2010-01-01 Teknimed Sas Composition adhesive pour comblement osseux a base de phosphatede calcium.
US8409538B2 (en) * 2008-12-04 2013-04-02 Skeletal Kinetics Llc Tricalcium phosphate coarse particle compositions and methods for making the same
US8673364B2 (en) 2009-09-28 2014-03-18 Skeletal Kinetics, Llc Rapid setting high strength calcium phosphate cements comprising cyclodextrins
KR20180027641A (ko) 2011-02-02 2018-03-14 알파마 파머슈티컬스 엘엘씨 오피오이드 효능제 및 격리된 길항제를 포함하는 제약 조성물
CN107281216B (zh) * 2017-06-16 2020-05-05 北京济美堂医药研究有限公司 含钙化合物的药物制剂

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB748402A (en) * 1951-11-08 1956-05-02 Avoset Company Improvements in or relating to methods of making gel-forming composition and resulting product
US3134719A (en) 1962-04-05 1964-05-26 American Cyanamid Co Calcium phosphates in tablet compressing
DE1228029C2 (de) 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3639169A (en) 1969-04-29 1972-02-01 Sucrest Corp Direct compression vehicles and method therefor
US3639168A (en) 1969-04-29 1972-02-01 Sucrest Corp Direct compression vehicles
US3821414A (en) * 1969-12-17 1974-06-28 Sucrest Corp Direct compression vehicle
CA1183328A (en) * 1980-12-12 1985-03-05 Thomas W. Gerard Compacting calcium phosphate
CA1325707C (en) * 1986-10-31 1994-01-04 Chihang Raymond Chu Granular tricalcium phosphate compositions suitable for direct compression tableting
JP3034592B2 (ja) * 1990-11-20 2000-04-17 わかもと製薬株式会社 経口用固形製剤及びその製造法
JP2521612B2 (ja) * 1992-05-20 1996-08-07 ウエイ・ミン・フアーマシユーテイカル・マニユフアクチヤリング・カンパニー・リミテツド 直接錠剤形成助剤
DE4220782A1 (de) * 1992-06-25 1994-01-05 Basf Ag Verfahren zur Herstellung von festen pharmazeutischen Retardformen
JPH07267850A (ja) * 1994-03-28 1995-10-17 Eisai Co Ltd 不快味を防止した医薬組成物及びその製造方法
US5766330A (en) * 1996-12-24 1998-06-16 Knights; Ralph J. Method of suspending insoluble calcium in protein composition
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
GB9825033D0 (en) * 1998-11-13 1999-01-13 Nycomed Pharma As Process
US6235322B1 (en) 1999-03-09 2001-05-22 Mintech, Inc. Highly soluble and stable mineral supplements containing calcium and magnesium
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
US6599544B2 (en) 2000-01-26 2003-07-29 American Micronutrients, Inc. Calcium enrichment composition and method for producing the same
WO2003013270A2 (en) * 2001-08-09 2003-02-20 Rhodia Inc. Calcium dietary supplement

Also Published As

Publication number Publication date
WO2005107722A3 (en) 2006-07-27
AU2005240137A1 (en) 2005-11-17
WO2005107722A2 (en) 2005-11-17
MXPA06012788A (es) 2007-04-02
JP5038130B2 (ja) 2012-10-03
CN102406593A (zh) 2012-04-11
EP2455067B1 (en) 2016-10-12
CA2565667C (en) 2013-10-29
JP2007536248A (ja) 2007-12-13
EP1755556A2 (en) 2007-02-28
US20050249813A1 (en) 2005-11-10
EP2455067A1 (en) 2012-05-23
EP1755556A4 (en) 2009-09-30
HUE033015T2 (en) 2017-11-28
US7226620B2 (en) 2007-06-05
CN1964701A (zh) 2007-05-16
CA2565667A1 (en) 2005-11-17
AU2005240137B2 (en) 2010-04-15
NZ550942A (en) 2011-02-25

Similar Documents

Publication Publication Date Title
ES2273510T3 (es) Procedimiento para preparar composiciones orales de calcio.
JP2015038123A (ja) 経口で分散可能な錠剤
US20050169986A1 (en) Fast disintegrating tablets
RU2500388C2 (ru) Маннит, распадающийся в полости рта
WO2008148733A2 (de) Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
ES2982524T3 (es) Comprimido de disgregación por vía oral
JP2009544706A (ja) 高用量の経口的に溶解可能／分解可能な凍結乾燥剤形
US8962036B2 (en) Disintegrable formulations of lanthanum carbonate
WO2010093561A1 (en) Particulate composition and the method of making the same
ES2606149T3 (es) Fosfato tricálcico directamente comprimible
ES2359377T3 (es) Celulosa microcristalina coprocesada y alcohol de azúcar como excipiente para formulaciones de comprimidos.
TW201311251A (zh) 新（三甲氧基苯胺基）嘧啶調配物
RS66288B1 (sr) Farmaceutska kompozicija u obliku tablete za žvakanje od diosmina ili flavonoidne frakcije koja obuhvata diosmin
CZ298224B6 (cs) Farmaceutická kompozice obsahující jako úcinnou látku ribavirin a zpusob její výroby